11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules

References

• Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Dohner K, Bentz M, Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 1999; 77: 266–281
   PubMed Web of Science ®Google Scholar
• Sadamori N, Han T, Minowada J, Sandberg A A. Clinical significance of cytogenetic findings in untreated patients with B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1984; 11: 45–51
   PubMed Web of Science ®Google Scholar
• Oscier D G, Stevens J, Hamblin T J, Pickering R M, Lambert R, Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br J Haematol 1990; 76: 352–358
   PubMed Web of Science ®Google Scholar
• Aoun P, Blair H E, Smith L M, Dave B J, Lynch J, Weisenburger D D. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2004; 45: 1595–1603
   PubMed Web of Science ®Google Scholar
• Dewald G W, Brockman S R, Paternoster S F, Bone N D, O'Fallon J R, Allmer C. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 287–295
   PubMed Web of Science ®Google Scholar
• Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580–1589
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, James M, Benner A, Lichter P. 11q Deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516–2522
   PubMed Web of Science ®Google Scholar
• Dickinson J D, Smith L, Sanger W G, Zhou G, Townley P, Lynch J. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukemia. Br J Haematol 2005
   PubMed Web of Science ®Google Scholar
• Ghia P, Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res 2000; 79: 157–173
   PubMed Web of Science ®Google Scholar
• Cuni S, Perez-Aciego P, Perez-Chacon G, Vargas J A, Sanchez A, Martin-Saavedra F M. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391–1400
   PubMed Web of Science ®Google Scholar
• Pedersen I M, Kitada S, Leoni L M, Zapata J M, Karras J G, Tsukada N. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002; 100: 1795–1801
   PubMed Web of Science ®Google Scholar
• Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 2777–2783
   PubMed Web of Science ®Google Scholar
• Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand A V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1996; 92: 97–103
   PubMed Web of Science ®Google Scholar
• Lopez-Giral S, Quintana N E, Cabrerizo M, Alfonso-Perez M, Sala-Valdes M, De Soria V G. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 2004; 76: 462–471
   PubMed Web of Science ®Google Scholar
• Till K J, Lin K, Zuzel M, Cawley J C. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 2002; 99: 2977–2984
   PubMed Web of Science ®Google Scholar
• Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N. CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001; 91: 474–480
   PubMed Web of Science ®Google Scholar
• Angelopoulou M K, Kontopidou F N, Pangalis G A. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 1999; 36: 178–197
   PubMed Web of Science ®Google Scholar
• Tusher V G, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121
   PubMed Web of Science ®Google Scholar
• Shen Y, Iqbal J, Xiao L, Lynch R C, Rosenwald A, Staudt L M. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol 2004; 5: 20
   PubMedGoogle Scholar
• Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Aalto Y, El-Rifa W, Vilpo L, Ollila J, Nagy B, Vihinen M. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001; 15: 1721–1728
   PubMedGoogle Scholar
• Bosch F, Villamor N. Zap-70 Expression in chronic lymphocytic leukemia: a new parameter for an old disease. Haematologica 2003; 88: 724–726
   PubMed Web of Science ®Google Scholar
• Klein U, Tu Y, Stolovitzky G A, Mattioli M, Cattoretti G, Husson H. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–1638
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh A A, Widhopf G, Simon R, Davis R E, Yu X. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647
   PubMed Web of Science ®Google Scholar
• Wiestner A, Rosenwald A, Barry T, Staudt L M, Wright G, Davis R E, Henrickson S E. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944–4951
   PubMed Web of Science ®Google Scholar
• Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416
   PubMed Web of Science ®Google Scholar
• Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahe B. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002; 116: 142–150
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Keating M, Do K A, O'Brien S, Huh Y O, Jilani I. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181–186
   PubMed Web of Science ®Google Scholar
• Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155–168
   PubMed Web of Science ®Google Scholar
• Stankovi T, Stewart G S, Byrd P, Fegan C, Moss P A, Taylor A M. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 2002; 43: 1563–1571
   PubMed Web of Science ®Google Scholar
• Stankovic T, Hubank M, Cronin D, Stewart G S, Fletcher D, Bignell C R. Microarray analysis reveals that TP53 and ATM mutant B-CLLs share a defect in activation of pro-apoptotic responses following DNA damage but are distinguished by major differences in activation of pro-survival responses. Blood 2003; 103: 291–300
   PubMed Web of Science ®Google Scholar
• Stankovic T, Stewart G S, Fegan C, Biggs P, Last J, Byrd P J. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 2002; 99: 300–309
   PubMed Web of Science ®Google Scholar
• Starczynski J, Simmons W, Flavell J R, Byrd P J, Stewart G S, Kullar H S. Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias. Am J Pathol 2003; 163: 423–432
   Web of Science ®Google Scholar
• Schaffner C, Stilgenbauer S, Rappold G A, Dohner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 748–753
   PubMed Web of Science ®Google Scholar
• Sembries S, Pahl H, Stilgenbauer S, Dohner H, Schriever F. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. Blood 1999; 93: 624–631
   PubMed Web of Science ®Google Scholar
• Schadt E E, Monks S A, Drake T A, Lusis A J, Che N, Colinayo V. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297–302
   PubMed Web of Science ®Google Scholar
• Kirst M, Myburg A A, De Leon J P, Kirst M E, Scott J, Sederoff R. Coordinated genetic regulation of growth and lignin revealed by quantitative trait locus analysis of cDNA microarray data in an interspecific backcross of eucalyptus. Plant Physiology 2004; 135: 2368–2378
   PubMed Web of Science ®Google Scholar
• Bauvois B, De Meester I, Dumont J, Rouillard D, Zhao H X, Bosmans E. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer 1999; 79: 1042–1048
   PubMed Web of Science ®Google Scholar
• Aldinucci D, Poletto D, Lorenzon D, Nanni P, Degan M, Olivo K. CD26 expression correlates with a reduced sensitivity to 2′-deoxycoformycin-induced growth inhibition and apoptosis in T-cell leukemia/lymphomas. Clin Cancer Res 2004; 10: 508–520
   PubMed Web of Science ®Google Scholar
• Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271: 21514–21521
   PubMed Web of Science ®Google Scholar
• Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036–15042
   PubMed Web of Science ®Google Scholar
• Chen L, Wildhopf G, Huynh L, Rassenti L, Rai K R, Weiss A. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002; 100: 4609–4619
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775
   PubMed Web of Science ®Google Scholar